Aliso Viejo, California, March 23, 2021 – Visionary Ventures today announced the closing of Visionary Venture Fund II with $114MM in committed capital. The Fund, which was strongly supported by existing and new investors, continues the firm’s strategy of partnering with Ophthalmology and Optometry Key Opinion Leader (KOL) limited partners to invest in ophthalmic pharmaceuticals and medical devices. Fund II enjoys investment and input from over 80 KOL experts spanning the front and back of the eye.
OIS Investor Perspectives Panel with Jeffry Weinhuff, Visionary Managing Partner, along with KKR, NEA, OrbiMed, & HIG
Ophthalmology Innovation Summit Year in Review – Investor Perspectives
Arjun Arora, Director – KKR
Ali Behbahani, MD, General Partner – NEA
Anat Naschitz, Managing Director – OrbiMed
Bruce Robertson, Managing Director – H.I.G. Capital
Jeffry Weinhuff, Managing Partner – Visionary Venture Fund
William J. Link, PhD, Managing Partner – Flying L Partners
Orange County Business Journal (OCBJ) interviews Visionary Ventures managing partner Jeffry Weinhuff and a Flying L managing partner Bill Link about investing in ophthalmology.
Jeffry Weinhuff, Visionary Managing Partner, Interviewed about Life Science Investing for the Long Haul
Q&A with Jeffry Weinhuff from Visionary Ventures on how life science investors view the current COVID-19 climate, what opportunities might arise, and what health care innovations are more important now more than ever.
Jeff discusses the value of OIS for the venture community and the success of Visionary Ventures.
Orange County-based VC Visionary Ventures Fund 1 last week released its 2018 executive summary showing it closed the year with a 33% internal rate of return, ranking it among the top performing VC funds in the U.S.
Jeffry Weinhuff, discusses how ophthalmologists, entrepreneurs, strategic buyers, and venture capitalists partner for success.
PWC Healthcare MoneyTree Report Q2 2017 Names Visionary Ventures the Number 3 Most Active Venture Fund in Healthcare
PWC Healthcare MoneyTree Report Q2 2017 Names Visionary Ventures the Number 3 Most Active Venture Fund in Healthcare.
The Economic Impact of the Ophthalmic Goods Manufacturing Industry on the Southern California Economy.